Nvidia researchers have introduced a new technique that dramatically reduces how much memory large language models need to track conversation history — by as much as 20x — without modifying the model itself. The method, called KV Cache Transform Coding (KVTC) , applies ideas from media compression formats like JPEG to shrink the key-value cache behind multi-turn AI systems, lowering GPU memory dem...
Nvidia researchers have introduced a new technique that dramatically reduces how much memory large language models need to track conversation history — by as much as 20x — without modifying the model itself. The method, called KV Cache Transform Coding (KVTC) , applies ideas from media compression formats like JPEG to shrink the key-value cache behind multi-turn AI systems, lowering GPU memory demands and speeding up time-to-first-token by up to 8x. For enterprise AI applications that rely on agents and long contexts, this translates to reduced GPU memory costs, better prompt reuse, and up to an 8x reduction in latency by avoiding the need to recompute dropped KV cache values. Serving large language models at scale requires managing a massive amount of data, especially for multi-turn conversations and long coding sessions. Every time a user adds to a prompt, the system relies on stored memory to avoid recomputing the entire conversation history from scratch. However, this memory footprint grows rapidly, creating a severe bottleneck for latency and infrastructure costs. Why KV cache becomes a bottleneck at scale To power multi-turn AI applications like coding assistants or chat apps, large language models rely on a mechanism known as the key-value (KV) cache . This cache stores the hidden numerical representations for every previous token in a conversation. Because the model remembers the past conversation, it does not have to redundantly re-process the entire chat history each time the user submits a new prompt. However, for AI applications with long context tasks, this cache can easily balloon to multiple gigabytes. As models scale up and generate increasingly long reasoning chains, the KV cache becomes a critical bottleneck for system throughput and latency. This creates a difficult challenge for production environments. Because LLMs are highly memory-bound during inference, serving multiple users simultaneously is constrained by GPU memory exhaustion rather than ...
SlavkoSereda/iStock via Getty Images The Middle East has lost more than 12M boe/day of production since Iran effectively closed the Strait of Hormuz, ~7% of global liquids demand, and the region's output could fall as low as 6M bbl/day in a worst-case scenario, a 70% decline from pre-war levels, Rystad Energy said in a report Monday. "Further cuts from major Middle East oil producers cannot be rul...
SlavkoSereda/iStock via Getty Images The Middle East has lost more than 12M boe/day of production since Iran effectively closed the Strait of Hormuz, ~7% of global liquids demand, and the region's output could fall as low as 6M bbl/day in a worst-case scenario, a 70% decline from pre-war levels, Rystad Energy said in a report Monday. "Further cuts from major Middle East oil producers cannot be ruled out as storage tanks fill to the brim, bypass infrastructure approaches its limit, and the conflict shows no sign of a near-term resolution," Rystad's Aditya Saraswat said , adding that restoring output to pre-conflict levels could take months, depending on infrastructure and geopolitical conditions. Of the Persian Gulf region's 21M bbl/day pre-conflict base, excluding Iran, only 14M bbl/day remains online, but Rystad says supply is very fragile; for example, 6.5M bbl/day depends on pipelines that bypass the Gulf—the United Arab Emirates' ADCOP line to Fujairah and Saudi Arabia's East-West line to Yanbu—but this infrastructure has already been targeted in attacks and constrained by tanker availability. "There are no viable replacements for Arab Heavy and Arab Medium in the near term, triggering a historic supply crisis if the conflict is not resolved in the coming weeks," Saraswat wrote. Crude oil futures fell sharply Monday as Iran appeared to let some tankers through the Strait of Hormuz and U.S. Treasury Secretary Bessent said the U.S. is letting Iran continue to ship its own crude through the strait for now. "The [oil] complex is selling off... on reports that some oil tankers are proceeding through the Strait of Hormuz and as Trump appeals for help in escorting tankers through the strait," analysts at Ritterbusch said in a note. Also, m ember countries of the International Energy Agency could release more oil into the market from strategic stockpiles "as and if needed," after they agreed last week to a release of 400M barrels, Executive Director Fatih Birol sa...
Key Points CoreWeave's fourth-quarter revenue surged 110% year over year. The company plans to spend heavily to support its massive backlog, guiding for up to $35 billion in capital expenditures this year. At its current valuation, the market is already pricing in years of flawless execution and a massive swing to profitability. 10 stocks we like better than CoreWeave › Shares of artificial intell...
Key Points CoreWeave's fourth-quarter revenue surged 110% year over year. The company plans to spend heavily to support its massive backlog, guiding for up to $35 billion in capital expenditures this year. At its current valuation, the market is already pricing in years of flawless execution and a massive swing to profitability. 10 stocks we like better than CoreWeave › Shares of artificial intelligence (AI) cloud infrastructure provider CoreWeave (NASDAQ: CRWV) have had a wild ride since going public in March 2025. And while the stock is down significantly from its 52-week highs, it has crushed the broader market this year, rising nearly 20% year to date. But despite massive demand for cloud computing and a solid fourth-quarter update in late February, I am still not interested in buying the stock. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Why? The business is undoubtedly growing at a breathtaking pace, but the investment looks more like a speculative gamble than a durable long-term bet. And when you factor in the company's valuation, the setup looks even worse. The market is already pricing in not just continued hypergrowth, but a massive inflection into profitability that is far from guaranteed. Let me explain. Staggering sales momentum To be fair to the bulls, CoreWeave's top-line momentum is mind-boggling. The company is successfully positioning itself as the infrastructure backbone for the AI boom, providing the heavy-duty computing power that tech giants and developers desperately need. The evidence is in the numbers. In the fourth quarter of 2025, CoreWeave's revenue rose 110% year over year to roughly $1.6 billion. For the full year, total revenue skyrocketed 168% to $5.1 billion. And the growth is not expected to slow down. Management guided for 2026 revenue of $12 billion to $13 b...
nLIGHT (LASR +9.43%) Board of Directors member Raymond A. Link reported the sale of 25,404 shares of common stock in multiple open-market transactions from March 11, 2026 through March 13, 2026, for a total consideration of approximately $1.61 million according to the SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 25,404 Transaction value $1.6 million Post-transaction sha...
nLIGHT (LASR +9.43%) Board of Directors member Raymond A. Link reported the sale of 25,404 shares of common stock in multiple open-market transactions from March 11, 2026 through March 13, 2026, for a total consideration of approximately $1.61 million according to the SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 25,404 Transaction value $1.6 million Post-transaction shares (direct) 77,172 Post-transaction value (direct ownership) ~$4.83 million Transaction value based on SEC Form 4 weighted average purchase price ($63.48); post-transaction value based on March 13, 2026 market close ($62.60). Key questions How does this sale compare to Raymond Link's previous open-market dispositions? This transaction involved 25,404 shares, which is above the most recent median sale size of 18,982 shares for Link's sell transactions since March of last year, and notably larger than his prior November 2025 sale of 12,560 shares. This transaction involved 25,404 shares, which is above the most recent median sale size of 18,982 shares for Link's sell transactions since March of last year, and notably larger than his prior November 2025 sale of 12,560 shares. What proportion of Link's direct holdings was affected? The sale represented 24.77% of his direct common stock position, reducing holdings from 102,576 to 77,172 shares, with no change to indirect or derivative positions. The sale represented 24.77% of his direct common stock position, reducing holdings from 102,576 to 77,172 shares, with no change to indirect or derivative positions. What is the broader market context for this transaction? nLIGHT shares posted a 601.01% total return over the past year (as of March 13, 2026), and the shares sold were priced at a weighted average of around $63.48, near the closing price of $62.60, suggesting the sale captured current market highs without attempting to time a short-term top. Company overview Metric Value Price (as of market close March 13, 2026) $63.48 Mar...
Key Points Cormorant Asset Management increased its MoonLake Immunotherapeutics position by 2,361,260 shares in the fourth quarter; the estimated trade value is $27.86 million based on average quarterly prices. The quarter-end value of the stake rose by $43.11 million, a figure reflecting both trading activity and stock price movement. The fund held 4,355,433 MLTX shares valued at $57.40 million a...
Key Points Cormorant Asset Management increased its MoonLake Immunotherapeutics position by 2,361,260 shares in the fourth quarter; the estimated trade value is $27.86 million based on average quarterly prices. The quarter-end value of the stake rose by $43.11 million, a figure reflecting both trading activity and stock price movement. The fund held 4,355,433 MLTX shares valued at $57.40 million as of December 31, 2025. 10 stocks we like better than MoonLake Immunotherapeutics › Cormorant Asset Management disclosed a buy of 2,361,260 shares of MoonLake Immunotherapeutics (NASDAQ:MLTX) in its February 17, 2026 SEC filing, an estimated $27.86 million trade based on quarterly average pricing. What happened According to a SEC filing dated February 17, 2026, Cormorant Asset Management increased its stake in MoonLake Immunotherapeutics (NASDAQ:MLTX) by 2,361,260 shares during the fourth quarter. The estimated transaction value, based on the period’s average closing price, was $27.86 million. The quarter-end value of the position increased by $43.11 million, a figure that includes both additional shares and changes in the share price. What else to know This was a buy, lifting MoonLake Immunotherapeutics to 2.65% of Cormorant Asset Management, LP’s reportable U.S. equities as of December 31, 2025. Top five holdings after the filing: NASDAQ:PRAX: $280.00 million (15.9% of AUM) NASDAQ:BBOT: $223.84 million (12.7% of AUM) NASDAQ:ABVX: $182.05 million (10.3% of AUM) NASDAQ:EYPT: $151.00 million (8.6% of AUM) NASDAQ:RAPP: $91.85 million (5.2% of AUM) As of February 17, 2026, shares of MoonLake Immunotherapeutics were priced at $17.52, down nearly 60% over the past year and well underperforming the S&P 500’s roughly 19% gain in the same period. Company overview Metric Value Price (as of market close 2026-02-17) $17.52 Market Capitalization $1.24 billion Net Income (TTM) ($227.3 million) Company snapshot MoonLake Immunotherapeutics develops clinical-stage therapies, with a primary...
On February 17, 2026, Vestal Point Capital disclosed a new position in Terns Pharmaceuticals (TERN 1.10%), acquiring 4,500,000 shares worth $181.80 million. What happened According to a U.S. Securities and Exchange Commission (SEC) filing dated February 17, 2026, Vestal Point Capital established a new position in Terns Pharmaceuticals by purchasing 4,500,000 shares. The quarter-end value of the st...
On February 17, 2026, Vestal Point Capital disclosed a new position in Terns Pharmaceuticals (TERN 1.10%), acquiring 4,500,000 shares worth $181.80 million. What happened According to a U.S. Securities and Exchange Commission (SEC) filing dated February 17, 2026, Vestal Point Capital established a new position in Terns Pharmaceuticals by purchasing 4,500,000 shares. The quarter-end value of the stake stood at $181.80 million. What else to know Top five holdings after the filing: NASDAQ:ABVX: $256.22 million (9.4% of AUM) NASDAQ:ACLX: $190.71 million (7.0% of AUM) NASDAQ: TERN: $181.80 million (6.7% of AUM) NASDAQ:BMRN: $178.29 million (6.5% of AUM) NYSE:GMED: $111.32 million (4.1% of AUM) As of Monday, shares of Terns Pharmaceuticals were priced at $46.07, up a staggering 1,300% over the past year and significantly outperforming the S&P 500’s roughly 19% gain in the same period. Company overview Metric Value Price (as of Monday) $46.07 Market Capitalization $5 billion Net Income (TTM) ($94.44 million) Company snapshot Terns Pharmaceuticals develops small-molecule therapeutics targeting non-alcoholic steatohepatitis (NASH), obesity, and related metabolic diseases, with a pipeline including TERN-101, TERN-201, TERN-501, and TERN-601 in various clinical stages. It operates a clinical-stage biopharmaceutical business model, generating value through research, development, and potential future commercialization or licensing of proprietary drug candidates. Its primary customers are expected to be healthcare providers, hospitals, and patients affected by NASH, obesity, and metabolic disorders, pending successful clinical development and regulatory approval. Terns Pharmaceuticals is a clinical-stage biotechnology company focused on developing novel small-molecule therapies for NASH and metabolic diseases. The company leverages a differentiated pipeline with multiple candidates in Phase I and II trials, aiming to address significant unmet medical needs in liver and metabolic ...
Many cryptocurrency skeptics like to point to what they consider the lack of utility of such assets. One person who would disagree with that, at least in the case of Circle Internet Group's (CRCL +9.06%) chosen stablecoin, is Clear Street analyst Owen Lau. On the back of increased demand for USDC, Lau upgraded his recommendation on its No. 1 adopter on Monday. In response, market players eagerly s...
Many cryptocurrency skeptics like to point to what they consider the lack of utility of such assets. One person who would disagree with that, at least in the case of Circle Internet Group's (CRCL +9.06%) chosen stablecoin, is Clear Street analyst Owen Lau. On the back of increased demand for USDC, Lau upgraded his recommendation on its No. 1 adopter on Monday. In response, market players eagerly snapped up Circle's stock, sending it more than 9% higher on the day. Virtuous Circle The analyst changed his recommendation on Circle from hold to buy and raised his price target significantly -- it's now $136 per share, up from $92. According to reports, Lau's changed opinion is based on his observation that USDC is becoming notably more popular. He wrote in his Circle update that the coin is riding a wave of popularity for tokenized financial assets, among other platforms and services that benefit from having a reliable and readily available stablecoin. The prognosticator also observed increasing USDC balances in trading platforms offering decentralized finance prediction markets. Such markets have seen surging demand as bettors wager on all manner of events and outcomes. Another potential catalyst is the fusion of artificial intelligence (AI) technology and programmable financial systems; a stablecoin like USDC is ideal for such environments. Expand NYSE : CRCL Circle Internet Group Today's Change ( 9.06 %) $ 10.45 Current Price $ 125.83 Key Data Points Market Cap $28B Day's Range $ 119.77 - $ 126.50 52wk Range $ 31.00 - $ 298.99 Volume 19M Avg Vol 14M Gross Margin 5.88 % Making its bed, and lying in it Lau made several strong points in favor of USDC and, by extension, Circle. However, we should bear in mind that the company and the cryptocurrency are inextricably linked, so the company's success depends heavily on the coin's future. Given that, I'd be a little wary of the stock, though I think the analyst is spot-on about USDC's potential.
Key Points Several factors are driving demand for USDC, the pundit wrote in his update. In his view, much of this is due to the usefulness of the cryptocurrency rather than speculation. 10 stocks we like better than USDC › Many cryptocurrency skeptics like to point to what they consider the lack of utility of such assets. One person who would disagree with that, at least in the case of Circle Inte...
Key Points Several factors are driving demand for USDC, the pundit wrote in his update. In his view, much of this is due to the usefulness of the cryptocurrency rather than speculation. 10 stocks we like better than USDC › Many cryptocurrency skeptics like to point to what they consider the lack of utility of such assets. One person who would disagree with that, at least in the case of Circle Internet Group's (NYSE: CRCL) chosen stablecoin, is Clear Street analyst Owen Lau. On the back of increased demand for USDC, Lau upgraded his recommendation on its No. 1 adopter on Monday. In response, market players eagerly snapped up Circle's stock, sending it more than 9% higher on the day. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Virtuous Circle The analyst changed his recommendation on Circle from hold to buy and raised his price target significantly -- it's now $136 per share, up from $92. According to reports, Lau's changed opinion is based on his observation that USDC is becoming notably more popular. He wrote in his Circle update that the coin is riding a wave of popularity for tokenized financial assets, among other platforms and services that benefit from having a reliable and readily available stablecoin. The prognosticator also observed increasing USDC balances in trading platforms offering decentralized finance prediction markets. Such markets have seen surging demand as bettors wager on all manner of events and outcomes. Another potential catalyst is the fusion of artificial intelligence (AI) technology and programmable financial systems; a stablecoin like USDC is ideal for such environments. Making its bed, and lying in it Lau made several strong points in favor of USDC and, by extension, Circle. However, we should bear in mind that the company and the cryptocurrency are inextricably li...